| 1 | A Process audit attempting to identify current practise of the use of low aspirin in patients with angina, cerebrovascular accident and myocardial infarction by case review |
| 2 | A trial fibrillation and the use of anti-thrombotic prophylaxis in general practice |
| 3 | A study to assess the efficacy of opportunistic health promotion in the waiting area of a general practice |
| 4 | To investigate the documented use of aspirin in secondary prevention following myocardial infarction in one Northumberland general practice following the publication of local guidelines, and to discover if improvements in use can be made. |
| 5 | An audit to assess whether the prescribing of H2Antagonists and proton pump inhibitors to patients over the age of 45 years in a general practice is in accordance with established clinical guidelines |
| 6 | An audit of secondary prevention after myocardial infarction |
| 7 | An audit of the anticoagulation therapy of patients in a rural practice |
| 8 | An audit of influenza vaccine uptake |
| 9 | Anticoagulant therapy in elderly patients with atrial fibrillation in general practice and prevention of stroke |
| 10 | Audit of cholesterol assay and treatment in patients with coronary heart disease |
| 11 | Frequency and quality of reviews of patients with epilepsy |
| 12 | The appropriate prescribing of iron supplements |
| 13 | Discover whether current use of proton pump inhibitors and H2-Antagonists in a general practice conforms to standard guidelines |
| 14 | Audit of thyroid function testing in patients with hypothyroidism receiving replacement thyroxine |
| 15 | Topical beta-blockers as a treatment for glaucoma: are they being avoided in patients with reversible airways disease? |
| 16 | Looking at how the patients receiving warfarin in my training practice had the important facts about their anticoagulation recorded |
| 17 | Management guidelines for patients with functional or anatomic asplenia |
| 18 | The secondary prevention of hypercholesterolaemia in patients following coronary artery surgery |
| 19 | The use of midstream urine specimens (MSUs) in general practice |
| 20 | The prescribing of the combined oral contraceptive pill in women over 35 years of age who smoke are we adhering to current guidelines? |
| 21 | Secondary prevention of ischaemic heart disease an audit of hyperlipidaemia detection and management in a training practice |
| 22 | Royal college of general practitioners clinical guidelines for the management of low back pain: How closely are the guidelines being followed? |
| 23 | HbA1c results in known diabetics of the practice to ascertain if monitoring activity is adequate and treatment is achieving currently recommended target levels |
| 24 | Causes and effects of “Lost notes” episodes in general practice |
| 25 | Recording of Smoking status and smoking cessation advice |
| 26 | Are patients with a diagnosis of depression on therapeutic doses of tricyclic antidepressants, and is treatment maintained for an adequate length of time? An audit of one GP |
| 27 | Monitoring patients on thyroid replacement therapy |
| 28 | Use of Eradication for helicobacter in endoscopically proven peptic ulcer disease |
| 29 | Auditing the treatment of patients with duodenal ulcers against evidence based guidelines |
| 30 | An audit of prescribing of aspirin and beta blockers post MI |
| 31 | Patients waiting time for routine non-urgent appointments |
| 32 | Management of hypothyroidism in my practice |
| 33 | MMR-1 uptake audit in a NE of England GP Practice and ways of improving the uptake |
| 34 | A practice based audit of the control of hypertension in patients aged between 30 and 75 who have type 2 diabetes mellitus |
| 35 | Identify all male patients registered with the practice, between the ages of forty and sixty, with known ischaemic heart disease, to ascertain if they have been assessed for evidence of hypercholesterolaemia within the last 12 months |
| 36 | Documentation of folic acid supplements for pregnant women |
| 37 | The management of depression in GP an audit of documentation, follow-up and length of treatment with anti-depressant medication |
| 38 | The management of patients with epilepsy in a General Practice |
| 39 | Recorded data for aspirin prophylaxis in patients with Ischaemic Heart Disease |
| 40 | Follow up of patients on long term throxine replacement therapy usinf annual thyroid stimulating hormone levels (TSH) |
| 41 | Frequency that thyroid function tests had been checked in patients prescribed thyroxine |
| 42 | Long term, low dose proton pump inhibitor (PPI) prescribing in gastro-oesophagel reflux disease (GORD) |
| 43 | Proportion of pregnant women in our practice who smoke and to see whether the GP and community midwife had provided verbal and written information on the risks of smoking |
| 44 | Secondary prevention of ischaemic heart disease in patients under 70 years of age |
| 45 | How many people with hypertension and who are on bendrofluazide have had their electrolytes measured within the last year |
| 46 | Diagnosis and management of genital chlamydia infections |
| 47 | Notes of patients to assess management of continuing anti-coagulant therapy with warfarin in GP |
| 48 | Are statins used appropriately for patients at highest risk of coronary heart disease? |
| 49 | Payments received for contraceptive services provided by a GP |
| 50 | How may hypertensive patients have had their blood pressure measured in last six months? |
| 51 | Urea and electrolyte (U&E) testing in patients taking furosemide and digoxin |
| 52 | Combined oral contraception follow up in established pill users in GP |
| 53 | Lipid screening and management in patients with established coronary heart disease |
| 54 | The provision of family planning advice in a semi-rural practice |
| 55 | Thromboembolism prophylaxos in atrial fibrillation – are the patients in the practice with a diagnosis of atrial fibrillation receiving prophylaxis when appropriate |
| 56 | Are antibiotics prescribed to children consulting with upper respiratory tract infections |
| 57 | Folic acid supplemention in pregnancy for prevention of neural tube defect |
| 58 | Patient understanding of and compliance with prescribed inhaled corticosteroids |
| 59 | Repeat prescribing in an urban fund-holding practice |
| 60 | All patients who have suffered a myocardial infarction (MI) should have a blood cholesterol taken as part of their post-MI management |
| 61 | Management of patients after a myocardial infarct on lipid lowering drugs |
| 62 | Practices compliance with elements of an agreed protocol for the management of ischaemic heart disease |
| 63 | How well are we supporting and educating the epileptic patients in our practice? An audit of the information provided to epileptic patients about their condition |
| 64 | Are patients with congestive heart failure in general practice receiving angiotension converting enzyme (ACE) inhibitor therapy? |
| 65 | The incidence of patients with known hypercholesterolaemia not treated with drug therapy in the population covered by a general practice |
| 66 | Monitoring of thyroid and liver function in those patients on amiodarone in general practice |
| 67 | Management of patients with gout |
| 68 | Assessment of the monitoring of elderly patients with diabetes by annual review in residential homes compared with practice population |
| 69 | Amiodarone therapy and its monitoring in general practice: the necessity for guidelines to detect drug related adverse effects |
| 70 | Patients admitted as a medical emergency with a diagnosis of asthma, their attendance at the practice asthma clinic and their possession of a written self management plan |